These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 14674013
1. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells. Arakaki R, Ishimaru N, Saito I, Kobayashi M, Yasui N, Sumida T, Hayashi Y. Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013 [Abstract] [Full Text] [Related]
2. The role of caspase cascade on the development of primary Sjögren's syndrome. Hayashi Y, Arakaki R, Ishimaru N. J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566 [Abstract] [Full Text] [Related]
4. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Hayashi Y, Haneji N, Hamano H, Yanagi K. Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574 [Abstract] [Full Text] [Related]
8. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice. Haneji N, Hamano H, Yanagi K, Hayashi Y. J Immunol; 1994 Sep 15; 153(6):2769-77. PubMed ID: 8077681 [Abstract] [Full Text] [Related]
10. Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease. Legras F, Martin T, Knapp AM, Pasquali JL. Eur J Immunol; 1994 Jan 15; 24(1):181-5. PubMed ID: 8020554 [Abstract] [Full Text] [Related]
11. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Hayashi Y, Ishimaru N, Arakaki R, Tsukumo S, Fukui H, Kishihara K, Shiota H, Yasutomo K, Hayashi Y. Arthritis Rheum; 2004 Sep 15; 50(9):2903-10. PubMed ID: 15457459 [Abstract] [Full Text] [Related]
12. [Molecular mechanism on Sjögren's syndrome]. Sumida T, Matsumoto I, Namekawa T, Kita Y. Nihon Rinsho; 1995 Oct 15; 53(10):2395-400. PubMed ID: 8531344 [Abstract] [Full Text] [Related]
13. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands. Wang Y, Virji AS, Howard P, Sayani Y, Zhang J, Achu P, McArthur C. Arch Oral Biol; 2006 Jul 15; 51(7):558-66. PubMed ID: 16405863 [Abstract] [Full Text] [Related]
14. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome. Yanagi K, Ishimaru N, Haneji N, Saegusa K, Saito I, Hayashi Y. Eur J Immunol; 1998 Oct 15; 28(10):3336-45. PubMed ID: 9808203 [Abstract] [Full Text] [Related]
15. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis. Ishimaru N, Yoneda T, Saegusa K, Yanagi K, Haneji N, Moriyama K, Saito I, Hayashi Y. Am J Pathol; 2000 May 15; 156(5):1557-64. PubMed ID: 10793067 [Abstract] [Full Text] [Related]
16. Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus. Suzuki K, Makino M, Okada Y, Kinoshita J, Yui R, Kanazawa H, Asakura H, Fujiwara M, Mizuochi T, Komuro K. Lab Invest; 1993 Oct 15; 69(4):430-5. PubMed ID: 8231110 [Abstract] [Full Text] [Related]
17. Limited TCR repertoire of infiltrating T cells in the kidneys of Sjögren's syndrome patients with interstitial nephritis. Murata H, Kita Y, Sakamoto A, Matsumoto I, Matsumura R, Sugiyama T, Sueishi M, Takabayashi K, Iwamoto I, Saitoh Y, Nishioka K, Sumida T. J Immunol; 1995 Oct 15; 155(8):4084-9. PubMed ID: 7561120 [Abstract] [Full Text] [Related]